---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-214606"
form_type: "8-K"
ticker: "CYTK"
cik: "0001061983"
company_name: "CYTOKINETICS INC"
filed_at: "2026-05-08T23:59:59+00:00"
generated_at: "2026-05-14T19:39:38.751662+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cytokinetics prices $760M public offering of 11.34M shares at $71/sh

## Summary
- Offering of 9,859,155 shares at $71.00 per share; underwriters' option for 1,478,873 shares exercised in full.
- Net proceeds of approximately $760.2 million after underwriting discounts and expenses.
- Underwriters include Morgan Stanley, Goldman Sachs, J.P. Morgan, and Jefferies.
- Offering made under automatic shelf registration statement filed February 27, 2025.
- Prospectus supplement dated May 6, 2026 filed with SEC on May 7, 2026.

## SEC filing metadata
- accession: 0001193125-26-214606
- form_type: 8-K
- ticker: CYTK
- cik: 0001061983
- company_name: CYTOKINETICS INC
- filed_at: 2026-05-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1061983/000119312526214606/0001193125-26-214606-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1061983/000119312526214606/d138544d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-214606
- JSON: https://secwatch.observer/filing/0001193125-26-214606.json
- Plain text: https://secwatch.observer/filing/0001193125-26-214606.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.